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Background: DNA sequences called CRMs determine the precise patterns of gene expression.
Results:We identify and characterize the function of six novel hes1 CRMs.
Conclusion: HES1 expression is controlled by multiple distal CRMs in addition to the known promoter.
Significance: A powerful combination of computational and experimental methodologies enhances our knowledge of hes1
transcriptional control.
The expression profile of a gene is controlled by DNA
sequences called cis-regulatory modules (CRMs). CRMs can
function over large genomic distances and can be located many
kilobases away from their target promoters. hes1 is a key devel-
opmental gene that is overexpressed in certain cancers and is a
primary target of NOTCH signaling. Despite this, analysis of
hes1 transcriptional control has been limited solely to its pro-
moter.Here, we identify seven conservedDNA sequence blocks,
representing the hes1 promoter and six novel CRMs, within 57
kb upstream of the mouse hes1 gene. We identify 12 binding
sites for the RBP-JNOTCH effector and a singleM-CATmotif
within these regions. We validate RBP-J and TEAD family
occupancy in cells in culture and test the response of each of
these CRMs to active NOTCH. We show that two regions,
CRM5 and CRM7, function as enhancers, and four can repress
transcription. A pair of RBP-J motifs arranged in a tail-tail
configuration in CRM5 and theM-CATmotif in CRM7 are nec-
essary for enhancer function. Furthermore, these enhancers are
occupied by transcriptional co-activators and loop onto thehes1
promoter within the endogenous hes1 locus. This work demon-
strates the power of combining computational genomics and
experimental methodologies to identify novel CRMs and char-
acterize their function.
The Hairy and Enhancer of Split-1 (HES1) transcriptional
repressor is amember of theHES family of basic helix loop helix
transcription factors, which contains seven members in the
mouse (HES1–7). HES1 plays an important role in the control
of cellular proliferation and differentiation during develop-
ment. This is due, at least in part, to its ability to block the
activity of positively acting basic helix loop helix factors
involved in lineage determination, such as MASH1 during the
process of neurogenesis (1). However, HES1 can also directly
interact with co-repressor proteins, such as GROUCHO/TLE/
GRG and histone deacetylases, to actively repress target gene
expression (1–5). Indeed, HES1 is expressed in most undiffer-
entiated cell types in the developing mouse embryo, and
hes1/mutant mice show premature differentiation, progen-
itor cell depletion, and a consequent lethality (reviewed in Ref.
6).
HES1 is an essential effector of activated NOTCH. The
NOTCHpathway hasmany functions during development and
in the adult and has been implicated in the control of cell fate
decisions and the maintenance of progenitor cell identity. The
molecular mechanism of NOTCH signaling via the canonical
pathway is well understood. UponNOTCH receptor activation
by binding to the DELTA/JAGGED ligand expressed on adja-
cent cells, theNOTCH intracellular domain (NICD)2 is cleaved
and translocates to the nucleus where it interacts with the
RBP-J transcription factor. This leads to dissociation of co-re-
pressor proteins from RBP-J, and recruitment of transcrip-
tional co-activators such as MASTERMIND, p300, and PCAF
and the subsequent activation of RBP-J target genes, including
hes1. Consistentwith this, thehes1proximal promoter contains
two functional RPB-JK-binding sites (BSs), which have been
shown to play a role in mediating the response to NOTCH
(6–9).
NOTCH activation induces an oscillating expression of
HES1 with a periodicity of 1.5–3 h in the presomitic meso-
derm in the mouse embryo and in a variety of cell types such as
myoblasts, fibroblasts, and neural progenitor cells (10–12).
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which HES1 represses its own expression by binding to three
copies of its recognition motif, the N-box, in its proximal pro-
moter. Oscillatory expression of HES1 plays a role in the con-
trol of somite segmentation and the maintenance of cell iden-
tity in a number of progenitor cell populations and has been
implicated in embryonic stem (ES) cell fate choice. For exam-
ple, sustained HES1 expression in neural progenitors inhibits
both their proliferation and differentiation (12, 13).
HES1 expression can also be regulated by the Sonic hedge-
hog, c-Jun N-terminal kinase, transforming growth factor-,
extracellular signal-regulated kinase, and tumor necrosis fac-
tor- pathways in a variety of different cell types (14–19). This
suggests that multiple signaling inputs control HES1 expres-
sion in a context-dependent manner, and it raises the possibil-
ity that cross-talk between these pathways generates the correct
spatio-temporal pattern of HES1 expression.
In addition to its role during development, HES1 has been
implicated in the progression of cancer. Indeed, it has been
proposed that a common function of HES1 is to protect cancer
cells against differentiation-inducing signals, thus promoting
proliferation (20). As such, HES1 overexpression has been
detected in breast cancers, lung cancers, ovarian cancers, men-
ingiomas, rhabdomyosarcomas, and medulloblastomas (21–
27). Therefore, the identification of theDNAelements and pro-
teins that control HES1 expression levels will enhance our
understanding of the molecular pathways operating during
development and in disease.
The precise expression pattern of a gene is determined by the
interplay between DNA elements called CRMs, which include
both enhancers and silencers, their target promoters, the struc-
ture of the surrounding chromatin, and the spatial organization
of the locus in the nucleus. A CRM is typically several hundred
base pairs long and contains BSs for multiple transcription fac-
tors. The transcriptional regulatory function of a CRM is there-
fore determined by the concentration of active interacting tran-
scription factors expressed in a cell at a given time, whereas a
single gene can be regulated by multiple CRMs that interact to
determine the overall rate of transcription.
In this study, we use a combination of computational and
experimental techniques to identify and characterize the func-
tion of novel mouse hes1 CRMs in C2C12 myoblasts. We dis-
cover seven phylogenetically conserved sequence blocks,
including the proximal promoter, within 57 kb upstream of the
hes1 transcription start site (TSS). We identify recognition
motifs for the NOTCH effector RBP-J in each of these CRMs
and an M-CATmotif, a response element for the TEAD family
of transcription factors, in themost distal regionCRM7, andwe
verify RBP-J and TEAD2 binding in cells in culture. We show
that the newly identified conserved regions play a role in hes1
transcriptional control, and we provide evidence that the RPB-
JK-bound CRMs are targets of the NOTCH signaling pathway.
Two of the hes1 CRMs, CRM5 and CRM7, function as enhanc-
ers, andwedemonstrate that theRPB-JK andM-CATmotifs are
necessary for this activity. Consistent with an enhancer func-
tion, these regions are occupied by transcriptional co-activators
in C2C12 cells and are in close genomic proximity to the hes1
promoter in the nucleus.
EXPERIMENTAL PROCEDURES
Plasmid Constructs—pGL3-Venus-NLS, pSV40-Venus-
NLS, and pCMV-mCherry-NLS vectors have been described
previously (57). Amino acids 1744–2531 of NOTCH1 were
PCR-amplified as an XbaI-BamHI fragment from mouse
C2C12 cDNA and cloned into pcDNA3.1() to generate the
NICD expression vector. Fluorescent reporters containing hes1
CRMs cloned upstream of either the SV40 or the endogenous
hes1 promoter were generated as follows: the endogenous hes1
promoter sequence (952 to 122 nucleotides relative to the
TSS) was PCR-amplified from mouse genomic DNA and
inserted into pGL3-Venus-NLS as a BglII-HindIII fragment to
generate pHes1pro-Ven. Individual CRMs were then PCR-am-
plified as BglII-BamHI fragments (with the exception of CRM6,
which was amplified as a BglII-BclI fragment) from mouse
genomic DNA and cloned into the BglII site upstream of the
hes1 promoter in pHes1pro-Ven or the SV40 promoter in
pSV40-Venus-NLS. Mutation of the RBP-JK and M-CAT
motifs in the pCRM5-Hes1pro-Ven and pCRM7-Hes1pro-Ven
plasmids was carried out using the QuikChange site-directed
mutagenesis kit (Stratagene) as described by the manufacturer.
The fidelity of all constructs was verified by sequencing. Primer
sequences are provided in the supplemental material.
Cells—C2C12 cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) containing Glutamax without pyru-
vate and supplemented with 10% fetal bovine serum (FBS) at
37 °C and 5% CO2.
Flow Cytometry—1 105 cells per well were seeded in 6-well
plates. The next day cells were transfected with 1g of reporter
plasmid and 250 ng of pCMV-mCherry-NLS (to control for
transfection efficiency) using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Cells were incu-
bated for 48 h, washed twice with PBS, trypsinized, and then
harvested in 1 ml of growth medium. Cells were then washed
twice with ice-cold PBS and resuspended in 800 l of Cell Fix
(BD Biosciences). Fluorescent reporter activity was measured
in 10,000 transfected cells using the Partec CyFlow Space-3-
Laser 7-Color flow cytometry system with Partec FlowMax
software (PartecGmbH).Cellswere gated using forward scatter
and side scatter to exclude cell debris and clumps. To quantify
reporter activity, background fluorescence of untransfected
cells was subtracted, and the results were normalized against
mCherry. Each experiment was performed in triplicate.
Chromatin Immunoprecipitation (ChIP)—ChIP was per-
formed as described previously (28). Cross-linked chromatin
isolated from proliferating C2C12 cells was immunoprecipi-
tated using antibodies against RBP-JK, p300, TEAD2, YAP1 (all
Santa Cruz Biotechnology), NOTCH1, TEAD4 (Abcam),
TEAD1 (BD Biosciences), and anti-mouse or anti-rabbit GFP
antibodies as controls (BDBiosciences and SantaCruz Biotech-
nology). We used PCR primers spanning the potential RBP-JK
orM-CATmotifs within eachCRMto amplify the immunopre-
cipitated DNA. Primers specific to a hes1 upstream genomic
fragment where no RBP-JK- or TEAD-binding sites were
detected in silico were used as a control. ChIP data were ana-
lyzed by semi-quantitative PCR ensuring that amplificationwas
in the linear range. PCR products were separated on 1.5% aga-
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rose gels and quantified using the GeneTools software package
(Syngene). Each ChIP experiment was performed at least in
triplicate. ChIP primer sequences are provided in the supple-
mental material.
Chromosome Conformation Capture (3C)—3C experiments
to determine the spatial organization of the hes1 locus were
carried out using the procedure described previously (29).
Approximately 1  107 C2C12 cells were trypsinized, resus-
pended in 12.5 ml of growth medium, and cross-linked using
2% formaldehyde for 10 min at room temperature. 0.125 M gly-
cine was then added to stop the reaction. Nuclei were isolated
by resuspending the cells in ice-cold lysis buffer and incubating
for 90 min at 4 °C with stirring. The nuclei were pelleted and
resuspended in 0.5 ml of 1.2 restriction enzyme buffer con-
taining 0.3% SDS and incubated for 1 h at 37 °C with shaking.
Triton X-100 was added to a final concentration of 2%, and the
sample was incubated for a further 1 h at 37 °C with shaking.
400 units of BglII restriction enzyme was added, and the cross-
linked DNAwas digested overnight at 37 °C. 1.6% final concen-
tration of SDS was added, and the sample was incubated for 20
min at 65 °C to inactivate the restriction enzyme. The digested
DNA was then diluted to favor intramolecular ligations by the
addition of 6.125 ml of 1.15 ligation buffer. 1% final concen-
tration Triton X-100 was added, and the samples were incu-
bated for 1 h at 37 °C. TheDNAwas then ligated for 4 h at 16 °C
using 100 units of T4 ligase. 300 g of proteinase K was added,
and the samples were incubated overnight at 65 °C to reverse
the cross-links. Samples were then treated with 300 g of
RNase A for 30 min at 37 °C, and the DNA was purified by
phenol extraction and ethanol precipitation.
A bacterial artificial chromosome (BAC) clone (RP23 55P17)
covering the hes1 locuswas used to generate a control template.
3C ligation products were analyzed using TaqMan quantitative
PCR (qPCR). 3C qPCR primers and probe were designed using
Primer Express (Applied Biosystems). The sequences of these
are shown in the supplemental material. Real time PCR using
400 ng of each 3C product was carried out using an ABI Prism
7000 sequence detection system operated by ABI PRISM 7000
software. All reactions were performed in triplicate. To gener-
ate the relative cross-linking frequency C2C12, 3C qPCR values
were normalized to a GAPDH internal control and then
expressed relative to the BAC. Results are presented as a mean
value of three independent experiments.
Bioinformatics—Mouse hes1 CRMs were identified by com-
paring 140 kb of genomic sequence surrounding the mouse
hes1 gene with orthologous sequences from human, rat, Xeno-
pus, stickleback, Tetraodon, and fugu using the Regulatory
Module Graphical User Interface (57). The Regulatory Module
Graphical User Interface is a modified version of the Needleman-
Wunsch alignment algorithm. To identify the RBP-JK and TEAD
BSs, we searched position-specific scoringmatrices (PSSMs) from
the TRANSFAC data base and calculated the likelihood of factor
binding using BiFa, a custom discovery tool (30).
RESULTS
Bioinformatic Identification of Putative hes1 cis-Regulatory
Modules—Analysis of the DNA sequence elements controlling
mouse hes1 expression has been restricted to the proximal pro-
moter. We predicted that this small genomic fragment would
not include the complete repertoire of hes1 transcriptional con-
trol regions as distal enhancer and silencer elements that oper-
ate over large genomic distances are widespread in the mam-
malian genome. Given that conservation of sequence has been
used to identify functional regulatory regions for a growing
number of genes, we applied comparative genomics to identify
additional putative hes1 CRMs for biochemical and functional
testing.
To do this, we used a bioinformatics algorithm3 to compare
140 kb of mouse genomic sequence surrounding the hes1 gene
(Ensembl release 47) with orthologous sequences from human,
rat, Xenopus, stickleback, Tetraodon, and fugu, a group that
includes mammals as well as phylogenetically distant verte-
brates. The algorithmuses a 100-bp slidingwindow to compare
mouse sequences to other species in a stepwise manner and
compute the percentage similarity. This analysis identified
seven conservedDNA sequence blocks ranging from190 to 495
bp lying within 57 kb upstream of the mouse hes1 TSS (Fig. 1).
The complete sequence of themouse CRMs are provided in the
supplemental material. This included the previously identified
hes1 core promoter and upstream sequence, annotated as
CRM1 (8, 32), and an additional six regions of conservation
(CRM2–7) that have not been characterized previously. CRM1
(265 bp) is highly conserved between all the analyzed species.
CRM2 (300 bp), CRM6 (305 bp), and CRM7 (413 bp), located
4.5, 48, and 56 kb upstream of the hes1 TSS, are conserved
down to amphibians, whereas CRM3 (290 bp), CRM4 (190 bp),
andCRM5 (495 bp), located9, 14.5, and 37 kbupstreamof the
hes1 TSS, are conserved between mammals and teleost fishes.
We did not identify any conserved sequence blocks within the
hes1 intronic sequence, althoughweonly found a single block of
880 bp, conserved between mouse and amphibians within
50 kb of analyzed downstream hes1 sequence (data not
shown). This regionwas not included for further analysis due to
the lack of high probability RBP-JK BSs (see below).
Hes1 Conserved Sequence Blocks Function as Transcriptional
Regulatory Elements—HES1 plays an important role in the con-
trol of proliferation and lineage commitment in mouse C2C12
cells, a well characterized model of myogenic differentiation.
HES1 is expressed in an oscillatory manner in proliferating
C2C12 cells with a periodicity similar to that observed in the
presomitic mesoderm (21), whereas up-regulation of HES1 in
C2C12myoblasts in response to activeNOTCHcanblockmyo-
genic differentiation (33). C2C12 cells therefore represent an
ideal model system to study the mechanisms of hes1 transcrip-
tional control.
To characterize the transcriptional properties of the hes1
conserved sequence blocks, we generated a series of hes1 CRM
promoter Venus reporter constructs (Fig. 2). Individual CRM-
Pro constructs were then transiently transfected into C2C12
cells along with an mCherry expression vector to control for
transfection efficiency. Venus fluorescence in transfected cells
was then compared with that of the hes1 promoter alone using
flow cytometry. The results in Fig. 2A show that CRM5 and
3 K.W. Vance,D. J.Woodcock, S.Ott, J. E. Reid,D.M. Jeziorska, T. Bretschneider,
M. Komorowski, and G. Koentges, submitted for publication.
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CRM7 function as enhancers, whereas CRM3 and CRM4 func-
tion as repressors of the hes1 promoter in C2C12 cells. CRM5
enhances hes1 promoter activity2-fold and CRM7 enhances
3.2-fold, whereas CRM3 and CRM4 both repress the hes1 pro-
moter 3-fold. Although CRM2 and CRM6 had no effect on
the hes1 promoter in this assay, it is possible that they may still
play a role in the control of hes1 expression in a different cellu-
lar or developmental context. Consistent with this, we show
thatCRM2andCRM6can function to repress the activity of the
strong heterologous SV40 promoter suggesting that these ele-
ments have the ability to regulate gene expression (Fig. 2B). A
Hes1CRM2-SV40 reporter is 40% less active than the SV40
promoter alone, whereas a Hes1CRM6 reporter has roughly
50% the activity of the SV40 promoter. These assays therefore
delineate either transcriptional enhancer or silencer functions
for all of the hes1 conserved sequence blocks.
Hes1 CRMs Are Bound by the RBP-JK and TEAD Transcrip-
tion Factors—CRM function is mediated by the number and
arrangement of different types of transcription factor- binding
sites it contains. Given the important role played by NOTCH
signaling in the control of hes1 expression, we analyzed the
newly identified hes1 CRMs for RBP-JK BSs (Fig. 3A). RBP-JK is
amajormediator of the NOTCH signaling pathway. To do this,
we searched PSSMs from the TRANSFAC data base and calcu-
lated the likelihood of factor binding using BiFa, a custom dis-
covery tool (30). This analysis identified the two known func-
tional RBP-JK-binding sites in hes1 CRM1 validating our
approach (7–9). Strikingly, the results also revealed an addi-
tional 10 high probability RBP-JK-binding sites within the
newly identified mouse CRMs. The organization of these sites
within each CRM as well as phylogenetic conservation and
sequence similarity to the consensus high affinity PSSM is indi-
cated in Fig. 3A. Our analysis did not predict any RBP-JK BSs
with a high binding probability score in the intervening mouse
genomic sequences. This suggests that these regions represent
additional NOTCH-responsive transcriptional regulatory ele-
ments involved in the control of hes1 expression.
We additionally identified a phylogenetically conserved
M-CAT motif as the best hit in CRM7 that was not present in
any of the other CRMs (Fig. 3C). This motif was included for
further analysis as it is bound by the TEAD family of transcrip-
tion factors, TEAD1–4, which are known to play important
roles in the regulation of muscle-specific gene expression (34–
36). In addition, TEAD transcriptional activity can be regulated
FIGURE 1. Identification of conserved sequence blocks in the hes1 upstream sequence. Schematic representation of themouse hes1 upstream sequence
and theorthologous regions from thedifferent species used in the comparative analysis. Conserved sequences, identifiedusing aNeedleman-Wunschoptimal
alignment algorithm, are shown as different colored boxes, and red boxes indicate exon sequence. Numbers above each box indicate percentage sequence
similarity to mouse.
FIGURE2.hes1 conservedsequenceblocks functionasCRMs.A, regulation
of the hes1 promoter by the newly identified CRMs. B, hes1 CRM2 and -6
repress the activity of the heterologous SV40 promoter. hes1 CRM-Pro
reporter constructs (left)were transiently transfected intoproliferatingC2C12
cells alongwith anmCherry expression vector to control for transfection effi-
ciency. Fluorescence activitywasmeasured by flow cytometry. Venus activity
was measured in 10,000 cells and normalized against mCherry activity. The
data are displayed relative to the activity of the promoter construct alone (set
as 1). The results are indicated as a mean value S.D. of three independent
experiments.
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by HIPPO signaling (37–39), thus implicating an additional
NOTCH-independent pathway in the control of hes1
expression.
We carried out ChIP assays using chromatin from prolifer-
ating C2C12 cells to test whether RBP-JK and TEAD1, TEAD2
and TEAD4, but not TEAD3, as it is not expressed in C2C12
FIGURE 3. hes1CRMs are boundby the RBP-JK and TEAD2 transcription factors. A, identification of RBP-JKmotifs in the hes1CRMs using the BiFa discovery
tool. The position of each RBP-JK motif relative to the hes1 TSS is shown. Sequences matching the consensus high affinity PSSM are marked in gray and the
architecture of the RPB-JK BSs within each CRM is indicated. Conserved BSs aremarked by an asterisk. B, RBP-JK binds to hes1 CRMs in proliferating C2C12 cells.
ChIP assays were performed using either an antibody against RBP-JK or an isotype-specific anti-GFP control (n  4). The precipitated DNA fragments were
PCR-amplified using primers spanning the predicted RBP-JK BSswithin eachCRM. The control represents an intervening region in the hes1upstream sequence
in which no RBP-JK BSs were detected in silico. Analysis using an unpaired Student’s t test shows that RBP-JK occupancy at CRM1–6 is statistically significant
compared with a nonbinding control region. * indicates p 0.05; ** indicates p 0.01. C, position of the conservedM-CATmotif in hes1 CRM7 and sequence
matches to the consensus PSSM are shown. ChIP assays were performed in proliferating C2C12 cells using anti-TEAD1, anti-TEAD2, anti-TEAD4, or anti-GFP
(isotype control) antibodies. PrecipitatedDNA fragmentswere PCR-amplified usingprimers spanning thepredictedM-CATmotif in CRM7. To calculate specific
enrichment over input, the signal for each PCRwas quantified and divided by the input, and the background intensity,measured using an IgG isotope control,
was subtracted. D,modulation of hes1 CRM-pro reporter activity by active NOTCH. Hes1CRM-reporter constructs were co-transfected into C2C12 cells along
with a 1:1 ratio of reporter to NICD overexpression vector or an empty control vector to make the total amount of DNA transfected in each case equal. The
results are presented as fold induction relative to the activity of each reporter in the absence of NICD and represent a mean  S.D. of three independent
experiments.
hes1 Transcriptional Control
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cells (40, 41), can bind to the endogenous hes1 CRMs as pre-
dicted. Cross-linked chromatin was immunoprecipitated using
antibodies against RBP-JK, TEAD1, TEAD2, TEAD4, or a non-
specific isotype control, and we used specific PCR primers
spanning the potential transcription factor-binding site motifs
within each CRM to amplify the immunoprecipitated DNA.
Consistent with published data, the results in Fig. 3B show
that RBP-JK binds CRM1. Additionally, we detected specific
RBP-JK binding to all newly identified CRMs, except CRM7,
compared with the IgG control. A low level of background sig-
nal was obtained using primers to amplify a randomly selected
control region of the hes1 upstream sequence where no RBP-
JK-binding sites were detected in silico. These results therefore
verify RBP-JK binding to six of the seven regions that were pre-
dicted computationally. Moreover, RBP-JK occupancy is not
uniform across these regions and appears higher at the CRMs
containing multiple predicted RBP-JK BSs (Fig. 3B). For the
TEAD analysis, the results indicate that TEAD2, but not
TEAD1andTEAD4, specifically binds toCRM7 inproliferating
C2C12 cells (Fig. 3C). Furthermore, TEAD2 binding was not
observed at a control region that does not contain an M-CAT
motif. We therefore distinguish which specific member of the
TEAD transcription factor family is interacting with the iden-
tified regulatory motif in cells in culture, a finding that could
not be predicted using sequence analysis alone. Taken together,
our bioinformatics and experimental approach has identified
additional functional hes1 CRMs containing binding sites for
the RBP-JK and TEAD2 transcription factors.
Hes1 CRM2–6 Are Targets for the NOTCH Signaling
Pathway—As RBP-JK occupies six of the seven hes1 CRMs, we
tested whether the activity of the hes1 CRM-pro reporters can
be modulated by canonical NOTCH signaling. To do this, we
assayed fold induction for each hes1 CRM-pro construct in
response to NICD overexpression and compared this to the
promoter alone. We used a 1:1 ratio of reporter to overexpres-
sion vector as titration experiments showed that this was in the
range of the linear response for the promoter alone (data not
shown). We first tested whether NICD overexpression can
modulate the enhancer activity of CRM5 and CRM7 and
showed that NICD induces hes1 promoter reporter activity
5-fold and the CRM5-pro construct 9.2-fold (Fig. 3D). This
increased response of the CRM5-pro reporter to NICD overex-
pression indicates that the enhancer function of this region can
be increased by active NOTCH. Furthermore, in agreement
with our ChIP data showing that RBP-JK does not bind CRM7,
the enhancer activity of the CRM7-pro reporter is not induced
relative to the hes1 promoter in response to NICD (Fig. 3D). In
addition, this analysis also revealed that the hes1 CRM-pro
reporters containing the CRMs that have the ability to act as
repressors, i.e. CRM2–4 and -6, display a reduced response to
NICD overexpression compared with the promoter alone (Fig.
3D). This is consistent with the observation that a NOTCH-de-
pendent repressive effect has to be derepressed before these
elements can positively respond to active NOTCH. Together,
these data suggest that, in addition to the hes1 promoter, hes1
CRM2–6 are also able to integrate signals from the NOTCH
signaling pathway.
Contribution of RPB-JK and M-CAT Motifs to CRM5 and
CRM7 Enhancer Function—We next tested whether the
RBP-JK and M-CAT motifs in CRM5 and CRM7 play a role in
mediating enhancer function. To do this, we mutated these
motifs within the Hes1CRM5-Pro and Hes1CRM7-Pro
reporter constructs, using mutations that have previously been
shown to disrupt factor binding (42, 43). The wild-type and
mutated constructs along and the hes1 promoter alone were
then transiently transfected into C2C12 cells, and fluorescence
activity was compared using flow cytometry.
We first analyzed the role of RBP-JK in CRM5 function.
CRM5 has the highest levels of RBP-JK binding as determined
using ChIP (Fig. 3B) and contains two predicted RBP-JK motifs
as follows: BS5.1 at 37,009 represents an exact match to the
consensus high affinity GTGGGAA site, and BS5.2 at position
37,121 contains a mutation at position 1 of the consensus
(Fig. 3A). These sites are organized in a tail-tail configuration
separated by 112 bp of genomic sequence. The results in Fig. 4A
reveal that both RBP-J BS5.1 and BS5.2 are necessary for
CRM5 enhancer function. Mutation of these sites individually
reduced CRM5 enhancer activity by 20% when compared
with the wild-type Hes1CRM5-Pro construct. However, muta-
tion of both RBP-JK BSs resulted in the complete loss of CRM5
enhancer function suggesting cooperativity between these
motifs. Furthermore, the increased response of the
Hes1CRM5-Pro construct to NICD overexpression is also
abrogated by mutation of both the RBP-JK BSs in CRM5 (Fig.
4B). Together, these data demonstrate that the enhancer activ-
ity of CRM5 is regulated by NOTCH signaling and that the
RBP-JK BSs in this region mediate the effect.
We next assessed the function of the RBP-JK and TEAD2 BSs
inCRM7.Consistentwith the finding in Fig. 3B that RBP-JKwas
not detected at CRM7 using ChIP, mutation of the RBP-JK BS
within CRM7 had no effect on CRM7 enhancer function (Fig.
4C). However, Fig. 4D shows that mutation of the M-CAT
motif strongly reduces CRM7 enhancer activity by 75%.
Taken together with the ChIP assays, the data suggest that
TEAD2 is an important determinant of CRM7 enhancer activ-
ity and that CRM7 is able to integrate signals from the HIPPO
pathway. These assays therefore demonstrate functionality for
several of the in silico predicted transcription factor-binding
sites in the hes1 enhancers.
Co-factor Occupancy on CRM5 and CRM7 Is Characteristic
of Enhancers—Transcription factors are known to function by
recruiting multiprotein co-activator and co-repressor com-
plexes. We therefore performed a series of ChIP experiments
on the endogenous hes1 locus to test for occupancy of CRM-
specific co-activators as predicted by protein-protein interac-
tion data.
The p300 histone acetyltransferase can be found in complex
with both the RBP-J andTEAD2 transcription factors (44, 45).
Importantly, p300 occupancy has also been shown to mark
transcriptional enhancers (46). We therefore tested for p300
binding at hes1 CRM3–5 and -7, as these regions regulated the
activity of the hes1 promoter in our reporter assays (Fig. 2A). In
addition, we used p300 occupancy at CRM1 as a positive con-
trol. The results in Fig. 5A demonstrate that p300 is enriched on
CRM1aswell as both enhancerCRMs, CRM5 andCRM7, com-
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pared with a nonspecific control. Furthermore, CRM3 and -4,
which functioned to repress the hes1 promoter in our reporter
assays, showedmarkedly reduced levels of p300. These data are
consistent with the finding that p300 occupancy can predict
enhancer activity in a tissue-specific manner (47) and correlate
with the transcriptional activity of these CRMs as measured
using reporter assays (Fig. 2).
RBP-JK has been shown to interact with the NICD upon
NOTCH activation (8, 33, 48). As CRM5 contains functional
RBP-J BSs, we carried out a ChIP assay using an anti-NICD
antibody to assess NICD occupancy at this region. This
revealed that NICD specifically binds to CRM5 as well as
CRM1, a knownNOTCH-responsive element that we used as a
positive control, in proliferating C2C12 cells (Fig. 5B). NICD
was not detected above background at a control region in the
hes1 upstream sequence containing no RBP-JK motifs. Taken
together, these results demonstrate that a RBP-JK-NCID-p300
transcription factor-cofactor complex occupies the CRM5
enhancer in C2C12 cells.
TEAD proteins contain a DNA binding domain but lack an
activation domain (49). TEAD2 has been shown to form a com-
plex with the YAP co-activator, a major effector of the HIPPO
signaling pathway, to regulate gene expression (50, 51). We
therefore tested for YAP occupancy at CRM7 in proliferating
C2C12 cells by ChIP. The results show specific enrichment of
PCR signal with primers for CRM7 using an anti-YAP antibody
(Fig. 5C). In addition, YAPbindingwas not detected at a control
region in the hes1 upstream sequence. This suggests that a
TEAD2-YAP-p300 complex is recruited to the functional
M-CATmotif within CRM7 to regulate hes1 expression in pro-
liferating C2C12 cells.
The identification of non-DNA-binding transcriptional co-
activators at CRM5 and CRM7 provides additional evidence
that these regions function as enhancers within the context of
the endogenous hes1 locus in cells in culture, and it also sug-
gests that their activity might be regulated in response to spe-
cific signaling pathways.
Hes1 Enhancer CRMs Loop onto Endogenous Promoter—Sev-
eral differentmodels have been proposed to explain howCRMs
can regulate transcription over large genomic distances. The
loopingmodel suggests that CRM-promoter communication is
mediated by direct interactions between proteins bound to dis-
tal regulatory elements and the promoter with a consequent
looping out of the interveningDNA (52–54).We therefore pre-
FIGURE 4. RBP-JK and M-CAT motifs are necessary for CRM5 and CRM7 enhancer function. A, transcriptional effect of mutating the RBP-JK BSs in the
Hes1CRM5-Pro reporter. B,mutation of the RBP-JK BSs in Hes1CRM5-Pro results in a reduced response to NICD overexpression. C, RBP-JK BSs in Hes1CRM7 do
not contribute to enhancer activity.D, contributionof theM-CATmotif toHes1CRM7-Pro reporter activity. TheRBP-JK andM-CATmotifsweremutated (verified
in Refs. 42, 43) within the Hes1CRM5-Pro and Hes1CRM7-Pro reporters. Constructs containing either the wild-type or mutated RBP-JK andM-CATmotifs were
co-transfected into C2C12 cells with an mCherry expression vector. A 1:1 ratio of reporter to NICD expression vector was used in B. Fluorescence activity was
measuredby flowcytometry. Venus activitywasmeasured andnormalized againstmCherry activity.A, C, andD,data aredisplayed relative to the activity of the
constructwith highest fluorescence intensity (set as 1). B, results are presented as fold induction relative to the activity of each reporter in the absence of NICD.
The results are indicated as the mean S.D. of at least two independent experiments.
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dicted that if CRM5 and CRM7 function as enhancers, they
would be in close spatial proximity to the hes1 promoter in the
nucleus. To test this, we performed 3C experiments to map the
genomic architecture of the hes1 locus. We measured genomic
interactions between a BglII fragment containing the hes1 pro-
moter and60 kb of upstream sequence encompassing all the
newly identified CRMs. To calculate the relative cross-linking
frequency, we used TaqMan qPCR to compare the amount of
3C PCR product obtained in HES1 expressing C2C12 cells to a
BAC clone covering the hes1 gene and upstream sequence as a
control.
The results in Fig. 6 are consistent with the proposed
enhancer function of CRM5 and CRM7 as identified using
reporter gene assays. Two large genomic regions in the hes1
upstream sequence appear in close proximity to the hes1 pro-
moter as compared with the intervening and flanking
sequences suggesting that these distal regions are looping onto
the promoter. Region I spans restriction fragment 7 that con-
tains CRM5 as well as fragments 8 and 9, and region II contains
fragments 11 and 12 that cover CRM7. A schematic depicting
the genomic architecture of the hes1 upstream locus relative to
the promoter is shown in Fig. 6C. Furthermore, additional 3C
experiments in synchronized C2C12 cells showed that this
organization does not change during the different phases of
HES1 oscillatory expression (data not shown). Our 3C-based
mapping of the spatial organization of the hes1 locus therefore
identifies regulatory interactions between genomic regions
containing the newly identified functional hes1 CRMs and the
endogenous promoter. Our analysis also raises the possibility of
combining comparative genomics with high throughput
3C-based assays to identify functional regions of the genome on
a large scale.
DISCUSSION
In this study, we used a combination of computational and
experimental methodologies to further define the mechanisms
of hes1 transcriptional control. In addition to the known hes1
promoter region, we identified six previously uncharacterized
conserved DNA elements within 57 kb of the hes1 TSS in
mouse.We demonstrated a transcriptional regulatory function
for four of these regions at the endogenous hes1 promoter in
C2C12 myoblasts. Two of the conserved sequence blocks,
CRM5 andCRM7, functioned as enhancers and displayed char-
acteristics of functional enhancer regions within the context of
the endogenous hes1 locus. These regions were marked by
binding of the p300 co-activator, which has been shown to
occupy active enhancers in the genome (46), and are in close
genomic proximity to the hes1 promoter within the nucleus.
Furthermore, the enhancer activity CRM5 could be increased
in response to activeNOTCH signaling. These data are consist-
ent with the finding that CRMs can be located many kilobases
away from the TSS of their target genes and can communicate
with target promoters over large genomic distances through
direct regulatory interactions. This work therefore extends the
repertoire of known hes1 transcriptional control elements to
include distal regulatory regions in addition to the previously
characterized hes1 proximal promoter.
The number and affinity of transcription factor-binding sites
in the control regions of target genes play a role in generating
the correct transcriptional response to signaling pathways and
interpreting transcription factor gradients. NOTCH signaling
is used in a variety of different developmental contexts in the
FIGURE 5. Enhancer associated co-activators occupy hes1 CRM5 and
CRM7 in C2C12 cells. ChIP assays were performed using antibodies against
p300 (A), NICD (B), and YAP or a nonspecific control (anti-GFP) (C). Input con-
sists of DNA extracted from sonicated nuclei. Precipitated DNA was PCR-am-
plifiedusingprimers spanning the indicated regions. Results are expressed as
specific enrichment over input. To do this, the signal for each PCR quantified,
divided by the input and the background value of an IgG isotope control, was
then subtracted.
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control of binary cell fate decisions, and the levels of the
NOTCH receptor and its ligands have been shown to oscillate
in a temporal manner in a number of progenitor cell popula-
tions (12, 55, 56). We identified a total of 12 RBP-J BSs in the
hes1 upstream region that are distributed solely within the
seven conserved sequence blocks and are absent from the inter-
veningDNA. Six of the predicted BSsmatched the core consen-
susmotif that has been used to define a high affinity RBP-J BS.
We then demonstrated that RBP-J protein occupies
CRMs1–6 in C2C12 cells in culture and that although the BS
within CRM7 represents a high affinity motif, the inability to
detect RBP-J at this region correlated with the observation
thatmutation of this BS did not affect functionality.We suggest
that the presence of multiple copies of RBP-J BSs in the hes1
upstream CRMs would enable hes1 to elicit a fast response to
variations in NOTCH signal strength at different stages of
development and would allow for the fine control of hes1
expression levels.
RBP-J can bind to its response element as amonomer.How-
ever, RBP-J BSs commonly occur in clusters in the transcrip-
tional control regions of it targets (57), for example, the Dro-
sophila single-minded (sim) gene contains 10 binding sites for
Suppressor of Hairless (Su(H)), the Drosophila RBP-J homo-
logue (58). Our data suggest that RBP-J occupancy is higher at
the hes1 CRMs that contain multiple predicted RBP-J BSs as
comparedwith the regions that contain only one (Fig. 3).More-
over, the number and arrangement of RBP-J BSs play a role in
the control of RBP-J target gene selectivity and the response to
NOTCH. It has been proposed that an inverted repeat of two
motifs separated by a short 15–19-nucleotide spacer, the
Su(H)-paired site (SPS) configuration, is the preferred recogni-
tion sequence (59) and that RBP-JK-mediated transactivation is
affected by changes in spacing, orientation, andmutation of the
individual BSs within this sequence (60). However, it appears
that the SPS motif functions as a core promoter element to
increase responsiveness to distal CRMs and cannot act as an
enhancer over large genomic distances (9). Our data are con-
sistent with this. We find that the mouse hes1 promoter con-
tains two RBP-J motifs arranged in the SPS configuration,
although the RBP-Jmotifs in the newly identified hes1 CRMs
do not contain the SPS architecture. CRM4, CRM6, and CRM7
contain a single RBP-Jmotif, and CRM3 contains a cluster of
three RBP-JBSswith a tail-head and tail-tail organization. The
predicted pairs of RBP-J BSs in hes1 CRM2 and CRM5 are
organized in a tail-tail conformation separated by an extended
spacer of 199 and 112 nucleotides, respectively. Experiments
using synthetic reporters have suggested that NOTCH activa-
tion of tail-tail RBP-Jmotifs is dependent on the surrounding
DNA sequence (9). Our reporter assays demonstrate that the
pairedRBP-JBS architecturewithinCRM5 is functional and is
necessary for the enhancer activity of the region. The results
also suggest cooperativity between the individual RPB-JK BSs in
CRM5 as the transcriptional response of a double mutant con-
struct containing both BSsmutatedwas greater than the sumof
the effects of the constructs containing single BS mutations. In
agreement with this, RBP-J proteins in complex with the
NICDandMastermind co-activators have been shown to coop-
eratively form dimers on DNA templates containing the high
FIGURE 6. Long range hes1 CRM-promoter interactions in C2C12 cells. A, schematic representation of the hes1 upstream sequence. Shaded boxes indicate
the position of the hes1 CRMs. Small vertical bars represent the positions of the BglII restriction sites. Below, the restriction fragments generated by BglII
digestion are annotated.Arrows indicate the location of the 3C qPCRprimers. B,quantification of genomic interactions between the hes1promoter region and
the indicated upstream genomic fragments. The y axis shows the relative cross-linking frequency. The x axis indicates the primers used in combination with
primer 1. Results are expressed relative to a BAC control containing equimolar amounts of all possible ligation products and are indicated as themean relative
cross-linking frequency  S.D. of three independent experiments. C, graphical representation of the genomic distances between the hes1 promoter, posi-
tioned at the center of the radar, and the indicated BglII fragments. Distance was calculated as 1/cross-linking frequency.
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affinity SPS sequence as well as several nonconsensus SPS vari-
ants (31, 61). These data therefore reveal a novel functional
architecture of paired RBP-Jmotifs within a distal regulatory
region in the mouse genome.
TEAD proteins contain a DNA binding domain but lack a
transactivation domain (24) and, as such, have been shown to
interact with the YAP co-activator, a component of the HIPPO
signaling pathway, to activate target gene expression (31).
HIPPO signaling has been indirectly implicated in the control
of hes1 as YAP1 activation in the mouse intestine results in
expansion of undifferentiated progenitor cells and a rapid
increase in HES1 expression (38). This effect is partially
dependent onNOTCH. In this study we demonstrate that both
TEAD2 and YAP occupy hes1 CRM7 in C2C12 cells and that
the enhancer activity of this region is dependent on the Tead2
BS. We therefore provide a direct molecular link between
HIPPO signaling and HES1 expression.
This work provides an increased understanding of the
molecular mechanisms operating to control the expression of
hes1, a key developmental gene that is also overexpressed in
certain cancers. It also illustrates, using a single gene, the power
of combining computational DNA sequence analysis with
experimental methodologies such as ChIP, 3C, and reporter
assays to identify and functionally characterize genomic regu-
latory regions.
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